HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase.

Abstract
Using two monoclonal antibodies directed against placental alkaline phosphatase (H17E2 and D20L) the immunohistological staining of testicular germ cell tumours was compared with that of a wide range of normal and malignant tissues. All seminomas and malignant teratomas tested gave strong positive labelling with H17E2 but were either negative or only patchily positive with D20L. Neither antibody gave any positive reaction on the normal tissues tested. All other malignancies were negative with both antibodies apart from two cases of ovarian and one case of endometrical cancer (strongly stained by H17E2) and three cases of colonic carcinoma (weakly and patchily stained by both H17E2 and D20L). This indicates that germ cell neoplasms generally express a form of placental alkaline phosphatase recognised by antibody H17E2.
AuthorsA A Epenetos, P Travers, K C Gatter, R D Oliver, D Y Mason, W F Bodmer
JournalBritish journal of cancer (Br J Cancer) Vol. 49 Issue 1 Pg. 11-5 (Jan 1984) ISSN: 0007-0920 [Print] England
PMID6362705 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • GPI-Linked Proteins
  • Isoenzymes
  • Alkaline Phosphatase
  • alkaline phosphatase, placental
Topics
  • Alkaline Phosphatase (analysis, immunology)
  • Antibodies, Monoclonal (immunology)
  • Dysgerminoma (enzymology)
  • Female
  • GPI-Linked Proteins
  • Humans
  • Immunoenzyme Techniques
  • Isoenzymes (analysis, immunology)
  • Male
  • Placenta (enzymology)
  • Pregnancy
  • Teratoma (enzymology)
  • Testicular Neoplasms (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: